ADMA — ADMA Biologics, Inc. stock price, charts and financials

QT40ADMA Biologics, Inc.

ADMA Biologics, Inc. (NASDAQ: ADMA) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
8.91
+0.17+1.95%
OverviewShort InterestFilings
ADMAQT40ADMA Biologics, Inc.·NASDAQ
8.91+1.95%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 28, 20264Statement of changes in beneficial ownership
Jul 17, 20264Statement of changes in beneficial ownership
Jun 02, 20268-KCurrent report
May 28, 20264Statement of changes in beneficial ownership
May 14, 20264Statement of changes in beneficial ownership
May 12, 20264Statement of changes in beneficial ownership
May 06, 20268-KCurrent report
May 06, 202610-QQuarterly report
May 04, 20268-KCurrent report
Apr 29, 2026SC 13GBeneficial ownership statement (passive)
Apr 15, 2026ARSAnnual report to shareholders
Apr 15, 2026DEFA14AAdditional proxy soliciting materials
Apr 15, 2026DEF 14ADefinitive proxy statement
Apr 03, 20264Statement of changes in beneficial ownership
Mar 27, 20268-KCurrent report
Mar 26, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 17, 20264Statement of changes in beneficial ownership
Mar 17, 20264Statement of changes in beneficial ownership
Mar 10, 20264Statement of changes in beneficial ownership
Mar 10, 20264Statement of changes in beneficial ownership
Mar 09, 20264Statement of changes in beneficial ownership
Mar 02, 20268-KCurrent report
Mar 02, 20264Statement of changes in beneficial ownership
Feb 26, 20263Initial statement of beneficial ownership
Feb 25, 20268-KCurrent report
#1 / 25 of 330
Page
▼
/ 14